Furthermore, in the context of cancer progression, Plexin-B2-SEMA4C signaling cascade can enhance cell invasion and migration by triggering downstream effector pathways such Met, ErbB2, and RhoA-dependent kinase [17]; Le et al., 2015). The gene discussed is SEMA4C; the disease is cancer.